Literature DB >> 31876902

Clinician vs Patient Reporting of Baseline and Postbaseline Symptoms for Adverse Event Assessment in Cancer Clinical Trials.

Thomas M Atkinson1, Amylou C Dueck2, Daniel V Satele3, Gita Thanarajasingam4, Jacqueline M Lafky4, Jeff A Sloan3, Ethan Basch1,5.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 31876902      PMCID： PMC6990818          DOI： 10.1001/jamaoncol.2019.5566

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN： 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  5 in total

1.  Note on the sampling error of the difference between correlated proportions or percentages.

Authors:  Q McNEMAR
Journal:  Psychometrika       Date:  1947-06       Impact factor: 2.500

2.  Patient-Reported Outcomes - Harnessing Patients' Voices to Improve Clinical Care.

Authors:  Ethan Basch
Journal:  N Engl J Med       Date:  2017-01-12       Impact factor: 91.245

3.  Patient-reported outcomes: an essential component of oncology drug development and regulatory review.

Authors:  Ethan Basch
Journal:  Lancet Oncol       Date:  2018-05       Impact factor: 41.316

4.  Missing Patients' Symptoms in Cancer Care Delivery--The Importance of Patient-Reported Outcomes.

Authors:  Ethan Basch
Journal:  JAMA Oncol       Date:  2016-04       Impact factor: 31.777

5.  Methods for Implementing and Reporting Patient-reported Outcome (PRO) Measures of Symptomatic Adverse Events in Cancer Clinical Trials.

Authors:  Ethan Basch; Lauren J Rogak; Amylou C Dueck
Journal:  Clin Ther       Date:  2016-04-02       Impact factor: 3.393
  5 in total
  8 in total

1.  Incidence of fatigue associated with immune checkpoint inhibitors in patients with cancer: a meta-analysis.

Authors:  I Kiss; M Kuhn; K Hrusak; T Buchler
Journal:  ESMO Open       Date:  2022-05-13

2.  Electronic symptom monitoring in patients with metastatic lung cancer: a feasibility study.

Authors:  Rasmus Blechingberg Friis; Niels Henrik Hjollund; Caroline Trillingsgaard Mejdahl; Helle Pappot; Halla Skuladottir
Journal:  BMJ Open       Date:  2020-06-17       Impact factor: 2.692

Review 3.  A Narrative Review on the Collection and Use of Electronic Patient-Reported Outcomes in Cancer Survivorship Care with Emphasis on Symptom Monitoring.

Authors:  Corina J G van den Hurk; Floortje Mols; Manuela Eicher; Raymond J Chan; Annemarie Becker; Gijs Geleijnse; Iris Walraven; Annemarie Coolbrandt; Maryam Lustberg; Galina Velikova; Andreas Charalambous; Bogda Koczwara; Doris Howell; Ethan M Basch; Lonneke V van de Poll-Franse
Journal:  Curr Oncol       Date:  2022-06-17       Impact factor: 3.109

4.  Expanding Beyond Maximum Grade: Chemotherapy Toxicity over Time by Age and Performance Status in Advanced Non-Small Cell Lung Cancer in CALGB 9730 (Alliance A151729).

Authors:  Melisa L Wong; Junheng Gao; Gita Thanarajasingam; Jeff A Sloan; Amylou C Dueck; Paul J Novotny; Aminah Jatoi; Arti Hurria; Louise C Walter; Christine Miaskowski; Harvey J Cohen; William A Wood; Josephine L Feliciano; Thomas E Stinchcombe; Xiaofei Wang
Journal:  Oncologist       Date:  2020-10-01

5.  Evaluating Treatment Tolerability Using the Toxicity Index With Patient-Reported Outcomes Data.

Authors:  Blake Langlais; Gina L Mazza; Gita Thanarajasingam; Lauren J Rogak; Brenda Ginos; Narre Heon; Howard I Scher; Gisela Schwab; Patricia A Ganz; Ethan Basch; Amylou C Dueck
Journal:  J Pain Symptom Manage       Date:  2021-08-08       Impact factor: 3.612

6.  Underreporting of Symptomatic Adverse Events in Phase I Clinical Trials.

Authors:  Zachary W Veitch; Daniel Shepshelovich; Christina Gallagher; Lisa Wang; Albiruni R Abdul Razak; Anna Spreafico; Philippe L Bedard; Lillian L Siu; Lori Minasian; Aaron R Hansen
Journal:  J Natl Cancer Inst       Date:  2021-08-02       Impact factor: 13.506

7.  Patient-Reported Outcomes in Clinical Trials Leading to Cancer Immunotherapy Drug Approvals From 2011 to 2018: A Systematic Review.

Authors:  Houssein Safa; Monica Tamil; Philippe E Spiess; Brandon Manley; Julio Pow-Sang; Scott M Gilbert; Firas Safa; Brian D Gonzalez; Laura B Oswald; Adele Semaan; Adi Diab; Jad Chahoud
Journal:  J Natl Cancer Inst       Date:  2021-05-04       Impact factor: 13.506

8.  The association of Health-Related Quality of Life and 1-year-survival in sarcoma patients-results of a Nationwide Observational Study (PROSa).

Authors:  Martin Eichler; Susanne Singer; Leopold Hentschel; Stephan Richter; Peter Hohenberger; Bernd Kasper; Dimosthenis Andreou; Daniel Pink; Jens Jakob; Robert Grützmann; Stephen Fung; Eva Wardelmann; Karin Arndt; Vitali Heidt; Sergio Armando Zapata Bonilla; Verena I Gaidzik; Helena K Jambor; Jürgen Weitz; Klaus-Dieter Schaser; Martin Bornhäuser; Jochen Schmitt; Markus K Schuler
Journal:  Br J Cancer       Date:  2022-01-20       Impact factor: 9.075
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.